For human tissues, prior experimental manipulations are impractical, and genomic alterations are employed. Somatic mutations mark subclones and their fates can be reconstructed with DNA sequencing ...

Poseida Therapeutics' lead allogeneic chimeric antigen receptor T-cell candidate it is co-developing with Roche will advance to Phase Ib.

By Pooja Toshniwal Paharia Study reveals that moderate fever temperatures (39°C) improve metabolism, proliferation, and ...

While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a serious complication of systemic lupus ...

This interesting study focuses on a previously reported positive correlation between translational efficiency and protein noise. This is unexpected as typically noise is inversely related to ...

Researchers are just now beginning to link specific genetic mutations to subsets of lupus patients, allowing physicians to target therapies ... the more powerful adaptive immune response, mobilizing T ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Rahul Banerjee, MD, FACP, assistant professor in the Division of Hematology and Oncology, University of Washington, dissects the limited data on T-cell therapies for multiple myeloma, infectious ...

Most boys treated with breakthrough gene therapy for a rare but deadly brain illness are faring well six years later, two new ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and ...

Donald Trump is set to hold a rally focused on immigration in Aurora, Colorado on Friday, where local officials have rejected ...